Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc Logo
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 10.1 USD 2.12% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Enfusion Inc?
Write Note

Enfusion Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Enfusion Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Enfusion Inc
NYSE:ENFN
Gross Profit
$116.9m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Salesforce Inc
NYSE:CRM
Gross Profit
$27.8B
CAGR 3-Years
17%
CAGR 5-Years
20%
CAGR 10-Years
23%
Palantir Technologies Inc
NYSE:PLTR
Gross Profit
$1.8B
CAGR 3-Years
34%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Applovin Corp
NASDAQ:APP
Gross Profit
$2.2B
CAGR 3-Years
35%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Intuit Inc
NASDAQ:INTU
Gross Profit
$12.8B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
13%
Adobe Inc
NASDAQ:ADBE
Gross Profit
$18.6B
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
18%
No Stocks Found

Enfusion Inc
Glance View

Market Cap
1.3B USD
Industry
Technology

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.

ENFN Intrinsic Value
9.38 USD
Overvaluation 7%
Intrinsic Value
Price

See Also

What is Enfusion Inc's Gross Profit?
Gross Profit
116.9m USD

Based on the financial report for Dec 31, 2023, Enfusion Inc's Gross Profit amounts to 116.9m USD.

What is Enfusion Inc's Gross Profit growth rate?
Gross Profit CAGR 3Y
26%

Over the last year, the Gross Profit growth was 13%. The average annual Gross Profit growth rates for Enfusion Inc have been 26% over the past three years .

Back to Top